Skip to main content

Advances in Therapy

Ausgabe 3/2023

Inhalt (37 Artikel)

Review

GLP-1 Agonists for Weight Loss: Pharmacology and Clinical Implications

Peyton W. Moore, Kevin Malone, Delena VanValkenburg, Lauren L. Rando, Brooke C. Williams, Hannah G. Matejowsky, Shahab Ahmadzadeh, Sahar Shekoohi, Elyse M. Cornett, Alan D. Kaye

Review

Effects of Biliary Phospholipids on Cholesterol Crystallization and Growth in Gallstone Formation

Helen H. Wang, Piero Portincasa, Min Liu, David Q.-H. Wang

Open Access Review

Hereditary Angioedema: Diagnosis, Clinical Implications, and Pathophysiology

Evan S. Sinnathamby, Peter P. Issa, Logan Roberts, Haley Norwood, Kevin Malone, Harshitha Vemulapalli, Shahab Ahmadzadeh, Elyse M. Cornett, Sahar Shekoohi, Alan D. Kaye

Review

Evolving Therapeutic Roles of Nasogastric Tubes: Current Concepts in Clinical Practice

Nalini Vadivelu, Gopal Kodumudi, Lisa R. Leffert, Doris C. Pierson, Laura K. Rein, Matthew S. Silverman, Elyse M. Cornett, Alan D. Kaye

Open Access Original Research

Experience and Daily Burden of Patients with Chronic Kidney Disease Not Receiving Maintenance Dialysis or Renal Transplantation

Nobutaka Yagi, Takeshi Shukunobe, Seiichiro Nishimura, Akira Mima

Open Access Original Research

Comparative Effectiveness of Biologics Across Subgroups of Patients with Moderate-to-Severe Plaque Psoriasis: Results at Week 12 from the PSoHO Study in a Real-World Setting

Charles Lynde, Elisabeth Riedl, Julia-Tatjana Maul, Tiago Torres, Andreas Pinter, Gabrielle Fabbrocini, Flavia Daniele, Alan Brnabic, Catherine Reed, Stefan Wilhelm, Thorsten Holzkämper, Christopher Schuster, Luis Puig

Open Access Original Research

Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity

Amol D. Dhamane, Mauricio Ferri, Allison Keshishian, Cristina Russ, Nipun Atreja, Cynthia Gutierrez, Birol Emir, Huseyin Yuce, Manuela Di Fusco

Open Access Original Research

Adherence and Persistence to Nusinersen for Spinal Muscular Atrophy: A US Claims-Based Analysis

David Fox, Tu My To, Arpamas Seetasith, Anisha M. Patel, Susan T. Iannaccone

Open Access Original Research

Once-Weekly Semaglutide Use in Type 2 Diabetes: Real-World Data from the SURE Netherlands Observational Study

Bruce H. R. Wolffenbuttel, Michel P. Brugts, Andrei-Mircea Catarig, Alice Clark, Maarten Kok, Aloysius G. Lieverse, Jaap van Soest

Open Access Original Research

Developing Artificial Intelligence Models for Extracting Oncologic Outcomes from Japanese Electronic Health Records

Kenji Araki, Nobuhiro Matsumoto, Kanae Togo, Naohiro Yonemoto, Emiko Ohki, Linghua Xu, Yoshiyuki Hasegawa, Daisuke Satoh, Ryota Takemoto, Taiga Miyazaki

Original Research

Continuous Glucose Monitoring System Profile of Women Stratified Using Different Levels of Glycated Hemoglobin (HbA1c) in Early Pregnancy: A Cross-sectional Study

Yashdeep Gupta, Charandeep Singh, Alpesh Goyal, Mani Kalaivani, Neerja Bhatla, Nikhil Tandon

Open Access Original Research

The Economic Burden of Chronic Myeloid Leukemia in Patients with Later Lines: Findings from a Real-World Analysis in Italy

Massimo Breccia, Francesca Chiodi, Aurelio Pio Nardozza, Diletta Valsecchi, Valentina Perrone, Diego Sangiorgi, Elisa Giacomini, Maria Chiara Rendace, Paola Coco, Eleonora Premoli, Luca Degli Esposti

Original Research

Establishment of a Nomogram for Predicting the Suboptimal Angiographic Outcomes of Coronary De Novo Lesions Treated with Drug-Coated Balloons

Xue Yu, Yijia Wang, Wenduo Zhang, Xinyue Wang, Na Jia, Yanan Zhang, Chenguang Yang, Peng Li, Feng Xu, Fusui Ji

Open Access Original Research

Continuity of Care Within a Single Patient Support Program for Patients with Rheumatoid Arthritis Prescribed Second or Later Line Advanced Therapy

A. Mark Fendrick, Philip Mease, Matthew Davis, Pankaj Patel, Wes Matthias, Dominic Nunag, Manish Mittal

Original Research

Population Pharmacokinetics of CMAB008 (an Infliximab Biosimilar) and Remicade® in Healthy Subjects and Patients with Moderately to Severely Active Rheumatoid Arthritis

Yin Su, Jing Li, Chenguang Wang, Xunmin Zhang, Sheng Hou, Huaizu Guo, Chenhui Deng, Lun Ou, Jinwei Wang

Open Access Original Research

Cost-Effectiveness of SAPIEN 3 Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement in German Severe Aortic Stenosis Patients at Low Surgical Mortality Risk

Karl H. Kuck, Reiner Leidl, Lutz Frankenstein, Thorsten Wahlers, Archita Sarmah, Pascal Candolfi, Judith Shore, Michelle Green

Open Access Original Research

Safety and Effectiveness of SB2 (Infliximab Biosimilar) in Adult Patients with Immune-Mediated Inflammatory Diseases: A Post-Marketing Surveillance in Korea

Dong W. Kim, Yousun Lee, Geuntae Kim, Sang H. Kim, Dae H. Cho, Jeongmin Choi, Yong H. Kwon, Younjin Park, Wooree Choi, Dong I. Park

Original Research

Effect of Food (Low and High Fat) on Pharmacokinetics of FCN-159, a Selective MEK Inhibitor, in Healthy Chinese Males

Jiangfan Li, Yan Tan, Kexin Li, Ai-Min Hui, Zhuli Wu, Pu Han, Zhen Wei, Jingjun Qiu, Lei Diao, Xuhong Wang

Open Access Original Research

The Frozen Elephant Technique Using a Novel Hybrid Prosthesis for Extensive Aortic Arch Disease: A Multicentre Study

Ali El-Sayed Ahmad, Miriam Silaschi, Michael Borger, Vahid Seidiramool, Marwan Hamiko, Sergey Leontyev, Andreas Zierer, Mirko Doss, Christian D. Etz, Peter Benedikt, Peter Bramlage, Farhad Bakhtiary

Open Access Original Research

Obesity Burden and Impact of Weight Loss in Saudi Arabia: A Modelling Study

Saleh A. Alqahtani, Hussain A. Al-Omar, Ali Alshehri, Abdulmohsen Abanumay, Hana Alabdulkarim, Ali Alrumaih, Mahmoud S. Eldin, Volker Schnecke

Open Access Original Research

Examining Real-World Adherence to Nusinersen for the Treatment of Spinal Muscular Atrophy Using Two Large US Data Sources

Bora Youn, Crystal M. Proud, Nasha Wang, Qiang Hou, Emma Viscidi, Susan Eaton, Angela D. Paradis, Bridget A. Neville, Nicole B. Johnson

Open Access Original Research

Observational Analysis of the Costs Associated with Acute Treatment of Breakthrough Migraine Attacks in Medicaid Patients Using Preventive Therapies

Linda Harris, Tom O’Connell, Jonathan J. Woolley, Gilbert L’Italien, Tamela Martin, Vladimir Coric, James A. Moren

Open Access Original Research

Cost-Effectiveness of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Single-Agent Pembrolizumab for High-Risk Early-Stage Triple-Negative Breast Cancer in the United States

Min Huang, Peter A. Fasching, Amin Haiderali, Weiguang Xue, Chelsey Yang, Wilbur Pan, Zheng-Yi Zhou, Peter Hu, Mitashri Chaudhuri, Celine Le Bailly De Tilleghem, Nicolas Cappoen, Joyce O’Shaughnessy

Open Access Original Research

An Adjusted Treatment Comparison Comparing Amivantamab Versus Real-World Clinical Practice in Europe and the United States for Patients with Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations

Christos Chouaid, Lise Bosquet, Nicolas Girard, Anna Kron, Matthias Scheffler, Frank Griesinger, Martin Sebastian, Jose Trigo, Santiago Viteri, Craig Knott, Bernardo Rodrigues, Nora Rahhali, Jedelyn Cabrieto, Joris Diels, Nolen J. Perualila, Claudio A. Schioppa, Jan Sermon, Raphael Toueg, Nicole Erdmann, Janka Mielke, Mehregan Nematian-Samani, Cristina Martin-Fernandez, Innocent Pfaira, Tracy Li, Parthiv Mahadevia, Jürgen Wolf

Open Access Original Research

The Increased Clinical and Economic Burden of Hyperkalemia in Medicare Patients Admitted to Long-Term Care Settings

James F. Neuenschwander, Alison R. Silverstein, Christie L. Teigland, Shambhavi Kumar, Edric Y. Zeng, Abiy T. Agiro, William J. Pottorf, W. Frank Peacock

Open Access Original Research

Healthcare Resource Utilization and Costs of Rivaroxaban Versus Warfarin Among Non-valvular Atrial Fibrillation (NVAF) Patients with Diabetes in a US Population

Jeffrey S. Berger, Veronica Ashton, François Laliberté, Guillaume Germain, Brahim Bookhart, Dominique Lejeune, Julien Boudreau, Patrick Lefebvre, Matthew R. Weir

Open Access Original Research

Expert Consensus on the Characteristics of Patients with Epstein–Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) for Whom Standard-Dose Chemotherapy May be Inappropriate: A Modified Delphi Study

Sridhar Chaganti, Arie Barlev, Sophie Caillard, Sylvain Choquet, Kate Cwynarski, Anke Friedetzky, Eva González-Barca, Natalia Sadetsky, Stefan Schneeberger, Dhanalakshmi Thirumalai, Pier L. Zinzani, Ralf U. Trappe

Open Access Brief Report

Once-Weekly Subcutaneous Semaglutide 2.4 mg Injection is Cost-Effective for Weight Management in the United Kingdom

Hera Sandhu, Weiwei Xu, Anamaria-Vera Olivieri, Christopher Lübker, Inger Smith, Vasileios Antavalis

Open Access Study Protocol

Dupilumab-Treated Patients with Asthma in the Real World: The RAPID Global Registry

Rebecca Gall, Neal Jain, Weily Soong, Russell A. Settipane, Changming Xia, Yi Zhang, Tmirah Haselkorn, Juby A. Jacob-Nara, Shahid Siddiqui

Open Access Publisher Correction

Publisher Correction to: Chlormethine Gel for Patients with Mycosis Fungoides Cutaneous T Cell Lymphoma: A Review of Efficacy and Safety in Clinical Trial and Real-World Settings

Ulrike Wehkamp, Marco Ardigò, Evangelia Papadavid, Christiane Querfeld, Neda Nikbakht

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gut molekulare Response, aber seltener ernste Nebenwirkungen.

Hereditäres Angioödem: Tablette könnte Akuttherapie erleichtern

05.06.2024 Hereditäres Angioödem Nachrichten

Medikamente zur Bedarfstherapie bei hereditärem Angioödem sind bisher nur als Injektionen und Infusionen verfügbar. Der Arzneistoff Sebetralstat kann oral verabreicht werden und liefert vielversprechende Daten.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.